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Abstract
Introduction: Female sex workers (FSWs) experience overlapping burdens of HIV, sexually transmitted infections and unin-
tended pregnancy. Pre-exposure prophylaxis (PrEP) is highly efficacious for HIV prevention. It represents a promising strategy
to reduce HIV acquisition risks among FSWs specifically given complex social and structural factors that challenge consistent
condom use. However, the potential impact on unintended pregnancy has garnered little attention. We discuss the potential
concerns and opportunities for PrEP to positively or negatively impact the sexual and reproductive health and rights (SRHR)
of FSWs.
Discussion: FSWs have high unmet need for effective contraception and unintended pregnancy is common in low- and mid-
dle-income countries. Unintended pregnancy can have enduring health and social effects for FSWs, including consequences of
unsafe abortion and financial impacts affecting subsequent risk-taking. It is possible that PrEP could negatively impact condom
and other contraceptive use among FSWs due to condom substitution, normalization, external pressures or PrEP provision by
single-focus services. There are limited empirical data available to assess the impact of PrEP on pregnancy rates in real-life set-
tings. However, pregnancy rates are relatively high in PrEP trials and modelling suggests a potential two-fold increase in con-
domless sex among FSWs on PrEP, which, given low use of non-barrier contraceptive methods, would increase rates of
unintended pregnancy. Opportunities for integrating family planning with PrEP and HIV services may circumvent these con-
cerns and support improved SRHR. Synergies between PrEP and family planning could promote uptake and maintenance for
both interventions. Integrating family planning into FSW-focused community-based HIV services is likely to be the most effec-
tive model for improving access to non-barrier contraception among FSWs. However, barriers to integration, such as provider
skills and training and funding mechanisms, need to be addressed.
Conclusions: As PrEP is scaled up among FSWs, there is growing impetus to consider integrating family planning services with
PrEP delivery in order to better meet the diverse SRHR needs of FSWs and to prevent unintended consequences. Programme
monitoring combined with research can close data gaps and mobilize adequate resources to deliver comprehensive SRHR ser-
vices respectful of all women’s rights.
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1 | INTRODUCTION
Female sex workers (FSWs) in low- and middle-income coun-
tries experience overlapping burdens of high HIV prevalence
alongside high rates of sexually transmitted infections (STIs)
and unintended pregnancy [1,2]. Despite these coexisting
reproductive health needs, in many settings family planning is
poorly integrated into sexual and reproductive health and
rights (SRHR) services for FSWs, which often maintain a nar-
row focus on HIV and STI prevention and treatment [3–5].
Dual protection, denoting consistent condom use together
with another effective contraceptive method, is currently the
recommended approach to minimize risk of HIV/STIs and
unintended pregnancy. However, the use of effective non-
barrier contraception methods among FSWs is sub-optimal,
resulting in high rates of unintended pregnancy [2]. Similarly,
FSWs’ condom use, even when the primary method of preg-
nancy prevention, is often inconsistent, particularly with non-
paying partners [6–8].
Pre-exposure prophylaxis (PrEP) is a relatively new inter-
vention being offered to FSWs and other populations with
high risk of HIV acquisition. Although the potential benefits
and acceptability of PrEP among FSWs have been previ-
ously established [9–14], specific consideration of the impli-
cations of PrEP for family planning in this population is
lacking.
Depending on approaches to scale-up, there is the possibil-
ity that PrEP programming could increase rates of unintended
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pregnancy among FSWs. Risk compensation, normalization of
PrEP use and external pressures for condomless sex could
impact on condom use, while PrEP provision within single-fo-
cus services that insufficiently cater to family planning needs
could impact use of other contraceptive methods. Drawing
from our experience in working with national PrEP implemen-
tation programmes, the purpose of this commentary is to
elaborate on the context in which PrEP is being implemented
with FSWs and the potential concerns and opportunities for
PrEP to impact unintended pregnancy and other aspects of
SRHR.
2 | DISCUSSION
2.1 | Context and interactions between PrEP and
SRHR
2.1.1 | Benefits of PrEP for FSWs
PrEP offers personal control over HIV, and is therefore a pre-
vention option of particular benefit to FSWs because it can
help counter pervasive social and structural factors that limit
FSWs’ capacity to consistently use condoms to prevent HIV,
including gender norms, criminalization, intersecting stigmas
and sexual and physical violence [9,15]. In particular, PrEP can
mitigate risks of HIV acquisition associated with condom non-
use or condom breakage [15,16], including protecting against
HIV acquisition with non-paying, emotional partners [17,18].
PrEP also provides an effective way to reduce risk of HIV for
FSWs and their partners who wish to conceive [19,20]. There
is strong evidence that PrEP is efficacious in preventing HIV
infection among women when used consistently and as
directed [21].
2.1.2 | Contraceptive use and unintended pregnancy
among FSWs
Preventing pregnancy may be the greater motivator for
FSWs to use condoms compared to HIV prevention [13,22].
FSWs across low- and middle-income countries experience
high rates of unintended pregnancy: in cohort studies with-
out SRHR interventions, the pooled incidence rate for unin-
tended pregnancies among FSWs is 27.1 per 100 person-
years (95% CI = 24.4 to 29.8) [2]. Use of effective non-bar-
rier contraceptive methods among FSWs is below 40% in
numerous settings across sub-Saharan Africa [7,23–25] with
few FSWs in the region using long-acting reversible contra-
ceptives (LARCs) – intrauterine devices and implants –
despite their superior effectiveness [2,26]. User-dependent
methods such as injections and pills are often used inconsis-
tently or incorrectly [27,28]. Injections are the most com-
monly used and often the only available non-barrier method
in this population [13,24,25,29] but are reported to have
acceptability concerns among FSWs due to side effects
which interfere with their ability to work [13,30]. Additional
barriers to access and uptake of contraception among FSWs
include stigma or refusal of service due to sex work, young
age or marital status, limited availability or choice of contra-
ceptive methods, lack of health workers trained in LARC pro-
vision and limited knowledge of contraceptive methods
[5,31–33].
2.1.3 | Risk compensation
The potential for individuals on PrEP to reduce their use of
condoms due to negation of HIV risk is a commonly voiced
concern [34]. Nonetheless, acceptability studies suggest that
FSWs consider PrEP a favourable user-controlled back-up
option for when condoms fail or cannot be used, rather than
an alternative [12,13,35]. Based on a recent meta-analysis,
individuals starting PrEP have a high burden of STIs [36]. Fur-
thermore, there is emerging evidence from open-label and
demonstration studies and implementation sites among gay,
bisexual and other men who have sex with men (MSM) that
condom use decreases among some men on PrEP, particularly
among those already engaging in condomless sex or other
high-risk behaviours [37–41]. However, modelling among
MSM suggest that if PrEP is accompanied by regular STI ser-
vices, increased detection and treatment may mitigate
increases in STI transmission [42,43]. While there is no cur-
rent evidence among FSWs of decreasing condom use or
other behaviours increasing vulnerability to STIs and unin-
tended pregnancy [44–46], implementation data are too lim-
ited to discount this possibility. It is possible that risk
compensation will increase over time as PrEP becomes more
normalized [39]. Importantly, price premiums for condomless
sex are already reported by FSWs in many settings [47–49],
and as community knowledge of PrEP increases, so too may
client demand and pressure for condomless sex [10,50,51]. Of
note, modelling in South Africa has suggested that condomless
sex may increase two-fold among FSWs on PrEP by lowering
negotiating power and increasing coercion by clients [51].
While undocumented, it is also possible that individuals in a
position of disparate power or economic control over FSWs
may coerce FSWs to use PrEP whether or not they consider
it as the most suitable HIV prevention option for their circum-
stances.
2.1.4 | Impacts of unintended pregnancy
Most concerns raised around the potential implications of con-
domless sex focus on STIs – perhaps given the predominance
of PrEP studies involving MSM in the literature. Although less
frequently considered, mistimed or unwanted pregnancies are
a potential adverse outcome of PrEP use that may have
enduring social and health consequences. Among FSWs, unin-
tended pregnancy is commonplace and is often followed by
unsafe abortion [33]. Restrictive abortion policies throughout
most of Africa result in three-quarters of abortions in the
region being unsafe, contributing to 10% of maternal deaths
[52–54]. Furthermore, restrictive donor policies prevent pro-
grammatic support for identifying safer termination options
for women, as referrals or counselling around pregnancy
options are prohibited under the renewed United States’ glo-
bal gag rule [55].
In addition to the immediate health risks of unintended
pregnancy due to unsafe abortion and high maternal mortality
in areas most affected by HIV [56], pregnancy and caring for
children has major economic implications for FSWs that can
lead to subsequent risk. While motivations for selling sex are
complex and multifactorial [57], one reason often reported is
the need for financial independence among women with chil-
dren who are not financially supported by a partner [57–59].
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Unintended motherhood may increase economic dependency
on sex work and pressure women to take more clients, accept
condomless sex for more money, or serve as a barrier to leav-
ing sex work, thus increasing or prolonging risk for HIV and
other STIs [59–62]. A study in India found that FSWs with
more children were more likely to report inconsistent condom
use and accept more money for condomless sex [60]. In Tan-
zania, sex workers reported increasing sexual risk behaviours
to help fund their children’s school fees [63]. Pregnancy and
childcare may also lead to women taking unplanned or
unwanted breaks from sex work, thus adding to household
insecurity [64]. Conversely, for some FSWs, responsibility to
care for children may be a motivator to use PrEP in order to
stay healthy and maintain their earning potential [12,35,63].
2.1.5 | Evidence from PrEP studies
Evidence of the impact of PrEP on pregnancy rates among all
women is scant. The FEM-PrEP randomized controlled trial
(RCT) did not show a significant impact of PrEP compared to
placebo on unintended pregnancy among women [65,66]. As
use of contraception was a condition of enrolment and sup-
plied to participants, this result suggests that PrEP does not
reduce the efficacy of hormonal contraception [67], but it can-
not be used to predict the influence of PrEP on behaviour in
real-life settings. Pregnancy incidence has not been reported
in contexts that would give a better indication of the real-
world effect of PrEP, specifically among FSWs, such as demon-
stration studies, open-label comparisons of women using ver-
sus not using PrEP, or monitoring of larger scale PrEP
programmes [44,45]. Nonetheless, pregnancies in PrEP trials
were relatively common among both PrEP and control groups
with rates comparable to general rates in developing countries
[68], even when baseline criteria had stipulated contraceptive
use and no current pregnancy intentions and provided access
to at least shorter acting contraceptive methods: the overall
pregnancy incidence was 10 per 100 person-years in both the
Partners PrEP and FEM-PrEP studies [65,69], and approxi-
mately 8 per 100 person-years in the FACTS 001 tenofovir
gel and VOICE trials [70,71]. High rates of unintended preg-
nancies have also been reported in older PrEP trials [22] and
trials of other HIV prevention technologies [72,73], often in
the context of free provision of contraceptives [69,73].
2.1.6 | Contraceptive method mix for PrEP users
Choice of contraceptive is important, and in FEM-PrEP, the
pregnancy rate was much higher among those using oral con-
traceptive pills (incidence rate 31.7 per 100 person years
overall) compared to injectables (incidence rate 1.6 per 100
person years) or long-acting or permanent methods (none
reported) [65]; similar findings were reported from VOICE
[74]. This highlights the need to promote and supply longer
acting methods and deliver high-quality contraceptive coun-
selling [72] in the context of PrEP provision. Importantly, many
PrEP trials provided oral and injectable contraceptives onsite
but referral for LARCs [65,74], which may have been a deter-
rent to accessing more effective contraception. Trials have also
indicated higher pregnancy incidence among new versus
established contraceptive users, especially among oral contra-
ceptive users, emphasizing the need for counselling support
for new users [65,74]. Recent findings from the ECHO contra-
ceptive trial showed no difference in HIV risk between three
commonly available contraceptive methods in Sub-Saharan
Africa [75]. However, just as high rates of pregnancy have
been observed in PrEP trials, high rates of HIV acquisition
were observed in the ECHO trial across all contraceptive
arms, despite the integration of HIV risk reduction counselling,
condom provision, HIV and STI testing and eventually PrEP,
when it became locally available. Considering there are unmet
HIV and family planning needs in the context of well-re-
sourced and closely monitored HIV and contraceptive trials,
the scale-up of these services requires effective service inte-
gration to meet the breadth of SRHR needs in targeted popu-
lations.
2.2 | Opportunities and considerations for family
planning and PrEP integration
There are opportunities to meet the HIV prevention needs of
many FSWs while minimizing additional unintended pregnancy
risk through the integration of PrEP and family planning ser-
vices. Such service integration would also enhance opportuni-
ties for STI prevention and treatment and could promote
more efficacious approaches such as LARCs and multipurpose
prevention technologies for combined HIV prevention and
contraception.
2.2.1 | Synergies between PrEP and family planning
services
PrEP and family planning services for FSWs are likely to be
complementary. PrEP adherence and maintenance among
FSWs with sustained high-risk behaviours remains a major
challenge, with studies consistently demonstrating low PrEP
continuation among FSWs even at one month [44,45,76,77].
Provision of complementary services such as STI testing has
been associated with longer maintenance of PrEP [77,78].
Integration of family planning may also facilitate PrEP uptake
and continuation, as women seeking contraception or wanting
to conceive may be ideal PrEP candidates. Regular monitoring
of individuals on PrEP also provides opportunities for contra-
ception renewal and vice versa. Building on these synergies
between family planning and PrEP may reduce the administra-
tive burden to both service providers and clients and pro-
motes more cost-effective service provision [79,80]. Shared
social, economic and structural factors underlying vulnerability
to both unintended pregnancy and HIV acquisition, such as
violence, substance use and financial insecurity, may also affect
uptake of PrEP and family planning [81,82]. Programmes
which address these factors may support uptake and adher-
ence to PrEP, contraception and condoms alike [83].
2.2.2 | Models of PrEP and family planning service
integration
Current programmes providing PrEP to FSWs are predomi-
nantly implemented through FSW-focused services, which
include drop-in centres and clinics led by community-based
organizations [84]. Acceptability studies indicate that these
focused services are often the preferred way for FSWs to
access healthcare due to staff friendliness, lower cost, shorter
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waiting times, privacy, proximity to places of work and greater
quality of care [8,81,85,86]. There are several advantages of
building upon this model for integrated PrEP and family plan-
ning delivery. FSW-focused services commonly utilize peer-
based prevention and community mobilization programmes
and may provide opportunities to address syndemic vulnera-
bilities as well as informational, structural and social barriers
to the use of PrEP and contraception, including condoms
[4,81,86]. Community mobilization approaches promoting
social cohesion, leadership and empowerment have been
empirically associated with reductions in HIV and STI acquisi-
tion and increased treatment adherence [83,87]. With appro-
priate training, leadership and buy-in, community health
workers and peer educators can play an important role in sup-
porting PrEP and reproductive health provision. Community-
supported models of care are already important for delivery
of antiretroviral therapy in numerous settings [88]. Providing
options for PrEP and family planning through mobile service
delivery may extend service access and acceptability among
FSW [13,89]. The potential of FSW-focused services to pro-
vide comprehensive SRHR care can be further realized by the
addition of pregnancy testing, STI management, gender-based
violence services and cervical cancer screening [3].
Alternative models for the integration of family planning and
HIV services have focused on antenatal or family planning ser-
vices [90,91]. There are emerging data supporting the feasibil-
ity of integrating PrEP into family planning clinics targeting
adolescent girls and young women [92,93], although these may
have limited utility and acceptability for FSWs due to potential
stigmatization. FSWs and women who are pregnant outside of
marriage are often stigmatized, shamed, denied care in public
clinics, or are provided limited contraceptive choice based on
assumptions about their needs and behaviours [5,94–97].
However, this model of integration may still be valuable in con-
texts where FSWs are already accessing services in public or
private antenatal or family planning facilities [85]. Lessons
learned from these studies highlight that PrEP and family plan-
ning integration does not only confer synchronized commodity
delivery in a common space; there is also a need to integrate
tools for screening, monitoring and evaluation, coordinate
demand generation activities and integrate training [92].
Family planning entails not only provision of contraception,
but also non-judgemental and non-coercive discussions around
method options, fertility desires and safer conception coun-
selling. Based on learnings from SRHR, regardless of integra-
tion model, providing multiple contraceptive options [98] and
counselling and provision of LARCs over other non-barrier
methods where possible [31,32] may optimize contraceptive
uptake and acceptability among FSW. Counselling on contra-
ceptive options should consider individuals’ existing contracep-
tive use as well as current needs, as oral contraceptives may
be less effective among new users in particular [65].
2.2.3 | Barriers to integration
There are several barriers to realizing integrated PrEP and
family planning services. Common reliance on donor-driven
funding schemes favour vertical, disease-specific programming,
thus limiting the availability of sufficient funding for adequate
family planning and STI services within HIV programmes
[99,100]. This is exacerbated by inadequate mobilization of
domestic funding for HIV prevention programmes, particularly
among key populations [101]. The management and procure-
ment of PrEP and family planning commodities through differ-
ent funding and sources may pose additional challenges to
integrated delivery. Furthermore, the community-based nature
of many services reaching FSWs and other key populations
[102] can limit the availability of staff with suitable qualifica-
tions and training to deliver LARCs [26,79,103]. Finally, there
is currently a lack of policy guidance to support implementers
to integrate family planning into their programmes, with most
national PrEP policies and guidelines making fleeting refer-
ences to including contraceptive counselling within a combina-
tion package of prevention services [104–106]. Means to
overcome these barriers without relying on referrals to other
services include task-shifting contraceptive administration to
lower-cadre healthcare workers [107,108] and collaborations
between family planning and HIV services to hold recurrent
“family planning days” at FSW-friendly community services
which are attended by trained personnel for LARC administra-
tion. Enabling policies, clear implementation guidelines and
adequate systems for commodity supply and distribution may
support task-shifting and service integration [109]. “Diagonal”
models of care which leverage the international vertical fund-
ing for PrEP and other HIV prevention programmes [110], and
incorporate it into existing SRHR services focused on FSWs,
may also facilitate more effective integration. Intersectional
stigmas remain major barriers to PrEP uptake among key pop-
ulations in many settings [111,112]. Interventions aimed at
mitigating PrEP-related stigmas in the community, as well as
during PrEP provision and family planning services, through
careful marketing and peer-led, confidential and non-judgemen-
tal services may potentiate PrEP uptake and retention and
integration with reproductive health services [13,81,89].
STI management is already commonly integrated in HIV
programmes for FSW [3]. However, many programmes among
FSWs in resource-limited settings currently rely on syndromic
management of STIs, and given that the majority of STIs are
asymptomatic, this approach is likely to result in untreated
STIs and ongoing transmission [113,114]. To uphold improve-
ments in SRHR through integrated PrEP delivery, there is
demonstrated need to invest in improvements for STI ser-
vices, including low-cost point-of-care STI tests where possible
[115], vaccination for human papilloma virus and viral hepati-
tis, and other modalities for STI management [116].
2.2.4 | Multipurpose devices for prevention of HIV
and pregnancy
Combined delivery of PrEP and hormonal contraception could
be a convenient and efficient means of simultaneously prevent-
ing HIV and unintended pregnancy. Multipurpose prevention
technologies for modern contraception and HIV are in early
development stages, including intravaginal ring and gel prepara-
tions. A dual-purpose intravaginal ring delivering dapivirine and
levonorgestrel has undergone Phase I trials through the MTN-
030/IPM-041 study in the US and demonstrated high tolerance
and safety [117]. However, similar technologies for PrEP deliv-
ery demonstrated only moderate effectiveness, reducing HIV
incidence by 27% [118] and 31% [119] in Phase III trials. Long-
acting multipurpose technologies have the potential to ease bar-
riers to adherence, and intravaginal rings have the advantage of
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providing direct delivery to the predominant site of viral trans-
mission among most women. However, one study among FSWs
in Tanzania found lower acceptability of the intravaginal ring
compared to other PrEP modalities [120]. Furthermore, while
long-acting injectable multipurpose technologies may have
greater acceptability [120], single-purpose injectable PrEP is
still under Phase III trial for PrEP efficacy and thus more imme-
diate interventions are needed [121]. In the near-term, this
might include options for co-packaging PrEP with oral contra-
ceptives. However, this should still be considered in light of the
limitations of oral contraceptives, in particular lower effective-
ness compared to LARCs and pill burden [65]. Finally, despite
synergies between HIV and unintended pregnancy risks, HIV
risks and pregnancy intentions are each dynamic and temporal
needs may not always synchronize. The ease of transitioning to
single-purpose prevention modalities due to change in needs or
fertility desires must also be considered.
3 | CONCLUSIONS
Given the significant social and health impacts of unintended
pregnancy for FSWs, there is impetus to consider family plan-
ning as an integral component of PrEP programming. Surpris-
ingly, the potential for unintended pregnancy in the provision
of PrEP use has garnered limited attention to date despite
well-documented concerns around condom migration and STI
risk. Bi-directional integration of PrEP and family planning
could have a broad positive impact on FSWs across low- and
middle-income countries. In view of the complex social and
structural influences on condom use, settings with low use of
non-barrier methods pose a major concern in terms of unin-
tended pregnancy risk and should be prioritized for integrated
delivery of PrEP and family planning. As PrEP is scaled up
among FSWs, it remains important to measure the unintended
consequences of PrEP as well as its benefits. Systematic col-
lection and reporting of implementation data pertaining to
PrEP, family planning and related outcomes will support the
optimization of integration strategies to meet the multifaceted
needs of FSWs. Furthermore, dedicated research is needed to
test the hypotheses that integrating contraception with PrEP
delivery improves PrEP continuation and decreases unin-
tended pregnancy and to compare models of PrEP and family
planning integration. These data can be used by researchers
and programmatic implementers alike to mobilize adequate
resources to deliver comprehensive SRH services respectful
of all women’s SRH needs and reproductive rights.
AUTHORS ’ AFF I L IAT IONS
1Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore,
MD, USA; 2Burnet Institute, Melbourne, Victoria, Australia; 3Department of Epi-
demiology and Preventive Medicine, Monash University, Melbourne, Victoria,
Australia; 4Department of Population Health, Aga Khan University, Nairobi,
Kenya; 5International Centre for Reproductive Health, Department of Public
Health and Primary Care, Ghent University, Ghent, Belgium; 6Department of
Infectious Diseases, The Alfred Hospital, Melbourne, Victoria, Australia; 7Doh-
erty Institute and Melbourne School of Population and Global Health, University
of Melbourne, Melbourne, Victoria, Australia
COMPET ING INTEREST
The authors have no competing interest to declare.
AUTHORS ’ CONTR IBUT IONS
MH proposed the initial concept. ALB took the lead role in writing the manu-
script, reviewing the literature and developing the initial framework. FHA, SS,
SL, MS, SB and MH provided valuable feedback into the content and structure
of the manuscript. All authors provided intellectual input on the contents and
perspective of the commentary.
ACKNOWLEDGEMENTS
The National Health and Medical Research Council provide funding to AB
through an Early Career Fellowship, FHA through a Postgraduate Scholarship,
SL as a Career Development Fellow (1090805), MH as a Principal Research
Fellow (1112297) and MS as a Senior Research Fellow (1136970). SB and SS
effort was funded by a grant from the National Institute of Nursing Research of
the National Institutes of Health (R01NR016650). The views expressed in this
publication are solely the opinion of the authors and do not necessarily repre-
sent the official views of the NHMRC, the NINR or other sponsors.
REFERENCES
1. Baral S, Beyrer C, Muessig K, Poteat T, Wirtz AL, Decker MR, et al. Burden
of HIV among female sex workers in low-income and middle-income countries: a
systematic review and meta-analysis. Lancet Infect Dis. 2012;12(7):538–49.
2. Ampt FH, Willenberg L, Agius PA, Chersich M, Luchters S, Lim MSC. Inci-
dence of unintended pregnancy among female sex workers in low-income and
middle-income countries: a systematic review and meta-analysis. BMJ Open.
2018;8:e021779.
3. Dhana A, Luchters S, Moore L, Lafort Y, Roy A, Scorgie F, et al. Systematic
review of facility-based sexual and reproductive health services for female sex
workers in Africa. Glob Health. 2014;10(1):1–28.
4. Moore L, Chersich MF, Steen R, Reza-Paul S, Dhana A, Vuylsteke B, et al.
Community empowerment and involvement of female sex workers in targeted
sexual and reproductive health interventions in Africa: a systematic review. Glob
Health. 2014;10(1):47.
5. Petruney T, Minichiello SN, McDowell M, Wilcher R. Meeting the contracep-
tive needs of key populations affected by HIV in Asia: an unfinished agenda.
AIDS Res Treat. 2012;2012:1–6.
6. Schwartz SR, Papworth E, Ky-Zerbo O, Sithole B, Anato S, Grosso A, et al.
Reproductive health needs of female sex workers and opportunities for
enhanced prevention of mother-to-child transmission efforts in sub-Saharan
Africa. J Fam Plann Reprod Health Care. 2017;43(1):50–9.
7. Lafort Y, Greener R, Roy A, Greener L, Ombidi W, Lessitala F, et al. Sexual
and reproductive health services utilization by female sex workers is context-
specific: results from a cross-sectional survey in India, Kenya, Mozambique and
South Africa. Reprod Health. 2017;14(1):13.
8. Katz KR, McDowell M, Green M, Jahan S, Johnson L, Chen M. Understand-
ing the broader sexual and reproductive health needs of female sex workers in
Dhaka, Bangladesh. Int Perspect Sex Reprod Health. 2015;41(4):182–90.
9. Cowan FM, Delany-Moretlwe S. Promise and pitfalls of pre-exposure prophy-
laxis for female sex workers. Curr Opin HIV AIDS. 2016;11(1):27–34.
10. Bekker L-G, Johnson L, Cowan F, Overs C, Besada D, Hillier S, et al. Combi-
nation HIV prevention for female sex workers: what is the evidence? Lancet.
2015;385(9962):72–87.
11. Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, et al.
High acceptability of HIV pre-exposure prophylaxis but challenges in adherence
and use: qualitative insights from a phase I trial of intermittent and daily PrEP
in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162–72.
12. Eakle R, Bothma R, Bourne A, Gumede S, Motsosi K, Rees H, et al. The
PrEP life: Female sex workers' perspectives on uptake and use of daily pre-ex-
posure prophylaxis for HIV prevention in South Africa. The 22nd International
AIDS Conference (AIDS 2018) Jul 23–27; Amsterdam; 2018.
13. Eakle R, Bourne A, Mbogua J, Mutanha N, Rees H. Exploring acceptability
of oral PrEP prior to implementation among female sex workers in South Africa.
J Int AIDS Soc. 2018;21:e25081.
14. Karagu R, Mukoma W, Nduta S, Kilonzo N, Eakle R, Kiragu M, et al. Willing-
ness to take daily oral HIV pre-exposure prophylaxis (PrEP) among young
women and female sex workers in Kenya. The 22nd International AIDS Confer-
ence (AIDS 2018); Jul 23–27; Amsterdam; 2018.
15. Shannon K, Strathdee SA, Goldenberg SM, Duff P, Mwangi P, Rusakova M,
et al. Global epidemiology of HIV among female sex workers: influence of struc-
tural determinants. Lancet. 2015;385(9962):55–71.
16. Masvawure TB, Mantell JE, Tocco JU, Gichangi P, Restar A, Chabeda SV,
et al. Intentional and unintentional condom breakage and slippage in the sexual
Bowring AL et al. Journal of the International AIDS Society 2020, 23:e25442
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25442/full | https://doi.org/10.1002/jia2.25442
5
interactions of female and male sex workers and clients in Mombasa, Kenya.
AIDS Behav. 2018;22(2):637–48.
17. Murray L, Moreno L, Rosario S, Ellen J, Sweat M, Kerrigan D. The role of
relationship intimacy in consistent condom use among female sex workers and
their regular paying partners in the Dominican Republic. AIDS Behav. 2007;11
(3):463–70.
18. Peitzmeier S, Mason K, Ceesay N, Diouf D, Drame F, Loum J, et al. A cross-
sectional evaluation of the prevalence and associations of HIV among female
sex workers in the Gambia. Int J STD AIDS. 2013;25(4):244–52.
19. Schwartz SR, Baral S. Fertility-related research needs among women at the
margins. Reprod Health Matters. 2015;23(45):30–46.
20. Duff P, Shoveller J, Feng C, Ogilvie G, Montaner J, Shannon K. Pregnancy
intentions among female sex workers: recognising their rights and wants as
mothers. J Fam Plann Reprod Health Care. 2015;41(2):102–8.
21. Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O'Reilly KR, Koechlin FM,
et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all popu-
lations. AIDS. 2016;30(12):1973–83.
22. MacQueen KMPMPH, Johnson LMA, Alleman PMA, Akumatey BM, Law-
oyin TMMPHF, Nyiama TMA. Pregnancy prevention practices among women
with multiple partners in an HIV prevention trial. J Acquir Immune Defic Syndr.
2007;46(1):32–8.
23. Schwartz S, Papworth E, Thiam-Niangoin M, Abo K, Drame F, Diouf D, et al.
An urgent need for integration of family planning services into HIV care: the
high burden of unplanned pregnancy, termination of pregnancy, and limited con-
traception use among female sex workers in Co^te d'Ivoire. J Acquir Immune
Defic Syndr. 2015;68:S91–8.
24. Braunstein SL, Ingabire CM, Kestelyn E, Uwizera AU, Mwamarangwe L,
Ntirushwa J, et al. High human immunodeficiency virus incidence in a cohort of
Rwandan female sex workers. Sex Transm Dis. 2011;38(5):385–94.
25. Surie D, Yuhas K, Wilson K, Masese LN, Shafi J, Kinuthia J, et al. Associa-
tion between non-barrier modern contraceptive use and condomless sex among
HIV-positive female sex workers in Mombasa, Kenya: a prospective cohort anal-
ysis. PLoS ONE. 2017;12:e0187444.
26. Morse J, Chipato T, Blanchard K, Nhemachena T, Ramjee G, McCulloch C,
et al. Provision of long-acting reversible contraception in HIV-prevalent coun-
tries: results from nationally representative surveys in southern Africa. BJOG.
2013;120(11):1386–94.
27. Luchters S, Bosire W, Feng A, Richter ML, King’ola N, Ampt F, et al. “A Baby
Was an Added Burden”: predictors and consequences of unintended pregnan-
cies for female sex workers in Mombasa, Kenya: a mixed-methods study. PLoS
ONE. 2016;11(9):1–20.
28. Sutherland EG, Alaii J, Tsui S, Luchters S, Okal J, King'ola N, et al. Contra-
ceptive needs of female sex workers in Kenya – a cross-sectional study. Eur J
Contracept Reprod Health Care. 2011;16(3):173–82.
29. Chanda MM, Ortblad KF, Mwale M, Chongo S, Kanchele C, Kamungoma N,
et al. Contraceptive use and unplanned pregnancy among female sex workers in
Zambia. Contraception. 2017;96(3):196–202.
30. Ochako R, Okal J, Kimetu S, Askew I, Temmerman M. Female sex workers
experiences of using contraceptive methods: a qualitative study in Kenya. BMC
Womens Health. 2018;18:105.
31. Rees H, Pillay D, Mullick S, Chersich M. Strengthening implant provision
and acceptance in South Africa with the ‘Any woman, any place, any time’
approach: an essential step towards reducing unintended pregnancies. S Afr
Med J. 2017;107(11):939–44.
32. Benova L, Cleland J, Daniele MAS, Ali M. Expanding method choice in
Africa with long-acting methods: IUDs, implants or both? Int Perspect Sex
Reprod Health. 2017;43(4):183–91.
33. Ippoliti NB, Nanda G, Wilcher R. Meeting the reproductive health needs of
female key populations affected by HIV in low- and middle-income countries: a
review of the evidence. Stud Fam Plann. 2017;48(2):121–51.
34. Alaei K, Paynter CA, Juan SC, Alaei A. Using preexposure prophylaxis, los-
ing condoms? Preexposure prophylaxis promotion may undermine safe sex.
AIDS. 2016;30(18):2753–6.
35. Reza-Paul S, Lazarus L, Doshi M, Hafeez Ur Rahman S, Ramaiah M, Maiya
R, et al. Prioritizing risk in preparation for a demonstration project: a mixed
methods feasibility study of oral pre-exposure prophylaxis (PREP) among female
sex workers in South India. PLoS ONE. 2016;11:e0166889.
36. Ong J. STIs incidence and prevalence in PrEP programmes – highlights
from a systematic review. 10th IAS Conference on HIV Science; Jul 21-24; Mex-
ico City; 2019.
37. Oldenburg CE, Nunn AS, Montgomery M, Almonte A, Mena L, Patel RR,
et al. Behavioral changes following uptake of HIV pre-exposure prophylaxis
among men who have sex with men in a clinical setting. AIDS Behav. 2018;22
(4):1075–9.
38. Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, et al.
Association of HIV preexposure prophylaxis with incidence of sexually transmit-
ted infections among individuals at high risk of HIV infection. JAMA. 2019;321
(14):1380–90.
39. Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle
JS, et al. Effects of pre-exposure prophylaxis for the prevention of HIV infection
on sexual risk behavior in men who have sex with men: a systematic review and
meta-analysis. Clin Infect Dis. 2018;67:676–86.
40. Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O,
et al. Preexposure prophylaxis for HIV infection integrated with municipal- and
community-based sexual health services. JAMA Intern Med. 2016;176(1):75–
84.
41. Montano MA, Dombrowski JC, Dasgupta S, Golden MR, Duerr A, Manhart
LE, et al. Changes in sexual behavior and STI diagnoses among MSM initiating
PrEP in a clinic setting. AIDS Behav. 2019;23(2):548–55.
42. Jenness SM, Weiss KM, Goodreau SM, Gift T, Chesson H, Hoover KW,
et al. Incidence of gonorrhea and chlamydia following human immunodeficiency
virus preexposure prophylaxis among men who have sex with men: a modeling
study. Clin Infect Dis. 2017;65(5):712–8.
43. Wilkinson AL, Scott N, Tidhar T, Luong P, El-Hayek C, Wilson DP, et al. Esti-
mating the syphilis epidemic among gay, bisexual and other men who have sex
with men in Australia following changes in HIV care and prevention. Sex Health.
2019;16(3):254–62.
44. Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA,
et al. HIV pre-exposure prophylaxis and early antiretroviral treatment among
female sex workers in South Africa: results from a prospective observational
demonstration project. PLoS Med. 2017;14:e1002444.
45. Mboup A, Behanzin L, Guedou FA, Geraldo N, Goma-Matsetse E, Giguere
K, et al. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV
prevention among female sex workers in Cotonou, Benin: a prospective obser-
vational demonstration study. J Int AIDS Soc. 2018;21:e25208.
46. Giguere K, Behanzin L, Guedou FA, Talbot D, Leblond FA, Goma-Matsetse
E, et al. PrEP use among female sex workers: no evidence for risk compensation.
J Acquir Immune Defic Syndr. 2019;83(3):257–64.
47. Alam N, Chowdhury ME, Mridha MK, Ahmed A, Reichenbach LJ, Streatfield
PK, et al. Factors associated with condom use negotiation by female sex work-
ers in Bangladesh. Int J STD AIDS. 2013;24(10):813–21.
48. Grosso AL, Lei EL, Ketende SC, Peitzmeier S, Mason K, Ceesay N, et al.
Correlates of condom use among female sex workers in The Gambia: results of
a cross-sectional survey. PeerJ. 2015;3:e1076.
49. Ntumbanzondo M, Dubrow R, Niccolai LM, Mwandagalirwa K, Merson MH.
Unprotected intercourse for extra money among commercial sex workers in
Kinshasa, Democratic Republic of Congo. AIDS Care. 2006;18(7):777–85.
50. UNAIDS. Sex workers’ hopes and fears for HIV pre-exposure prophylaxis:
recommendations from a UNAIDS consultation meeting. November 11–12,
2013; Johannesburg, South Africa: Wits Reproductive Health and HIV Institute;
2014.
51. Quaife M, Vickerman P, Manian S, Eakle R, Cabrera-Escobar MA, Delany-
Moretlwe S, et al. The effect of HIV prevention products on incentives to supply
condomless commercial sex among female sex workers in South Africa. Health
Econ. 2018;27(10):1550–66.
52. Gebremedhin M, Semahegn A, Usmael T, Tesfaye G. Unsafe abortion and
associated factors among reproductive aged women in Sub-Saharan Africa: a
protocol for a systematic review and meta-analysis. Syst Rev. 2018;7(1):130.
53. Say L, Chou D, Gemmill A, Tuncalp €O, Moller A-B, Daniels J, et al. Global
causes of maternal death: a WHO systematic analysis. Lancet Glob Health.
2014;2(6):e323–33.
54. Ganatra B, Gerdts C, Rossier C, Johnson BR Jr, Tuncalp €O, Assifi A, et al.
Global, regional, and subregional classification of abortions by safety, 2010–14:
estimates from a Bayesian hierarchical model. Lancet. 2017;390(10110):2372–
81.
55. Bingenheimer JB, Skuster P. The foreseeable harms of trump's global gag
rule. Stud Fam Plann. 2017;48(3):279–90.
56. Alkema L, Chou D, Hogan D, Zhang S, Moller A-B, Gemmill A, et al. Global,
regional, and national levels and trends in maternal mortality between 1990
and 2015, with scenario-based projections to 2030: a systematic analysis by the
UN Maternal Mortality Estimation Inter-Agency Group. Lancet. 2016;387
(10017):462–74.
57. Stoebenau K, Heise L, Wamoyi J, Bobrova N. Revisiting the understanding
of “transactional sex” in sub-Saharan Africa: a review and synthesis of the litera-
ture. Soc Sci Med. 2016;168:186–97.
58. Cange CW, LeBreton M, Saylors K, Billong S, Tamoufe U, Fokam P, et al.
Female sex workers’ empowerment strategies amid HIV-related socioeconomic
vulnerabilities in Cameroon. Cult Health Sex. 2017;19(10):1053–65.
Bowring AL et al. Journal of the International AIDS Society 2020, 23:e25442
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25442/full | https://doi.org/10.1002/jia2.25442
6
59. Beckham SW, Shembilu CR, Winch PJ, Beyrer C, Kerrigan DL. 'If you have
children, you have responsibilities': motherhood, sex work and HIV in southern
Tanzania. Cult Health Sex. 2015;17(2):165–79.
60. Reed E, Silverman JG, Stein B, Erausquin JT, Biradavolu M, Rosenberg A,
et al. Motherhood and HIV risk among female sex workers in Andhra Pradesh,
India: the need to consider women's life contexts. AIDS Behav. 2013;17(2):543–
50.
61. Papworth E, Schwartz S, Ky-Zerbo O, Leistman B, Ouedraogo G, Samadou-
lougou C, et al. Mothers who sell sex: a potential paradigm for integrated HIV,
sexual, and reproductive health interventions among women at high risk of HIV
in Burkina Faso. J Acquir Immune Defic Syndr. 2015;68 Suppl 2:S154–61.
62. Fielding-Miller R, Mnisi Z, Adams D, Baral S, Kennedy C. “There is hunger
in my community”: a qualitative study of food security as a cyclical force in sex
work in Swaziland. BMC Public Health. 2014;14(1):1–20.
63. Beckham SW, Shembilu CR, Winch PJ, Beyrer C, Kerrigan DL. ‘If you have
children, you have responsibilities’: motherhood, sex work and HIV in southern
Tanzania. Cult Health Sex. 2015;17(2):165–79.
64. Mbonye M, Nalukenge W, Nakamanya S, Nalusiba B, King R, Vandepitte J,
et al. Gender inequity in the lives of women involved in sex work in Kampala,
Uganda. J Int AIDS Soc. 2012;15 Suppl 1:17365.
65. Callahan R, Nanda K, Kapiga S, Malahleha M, Mandala J, Ogada T, et al.
Pregnancy and contraceptive use among women participating in the FEM-PrEP
trial. J Acquir Immune Defic Syndr. 2015;68(2):196–203.
66. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al.
Preexposure prophylaxis for HIV infection among african women. N Engl J Med.
2012;367(5):411–22.
67. Thomson KA, Baeten JM, Mugo NR, Bekker LG, Celum CL, Heffron R.
Tenofovir-based oral preexposure prophylaxis prevents HIV infection among
women. Curr Opin HIV AIDS. 2016;11(1):18–26.
68. Bearak J, Popinchalk A, Alkema L, Sedgh G. Global, regional, and subre-
gional trends in unintended pregnancy and its outcomes from 1990 to 2014:
estimates from a Bayesian hierarchical model. Lancet Glob Health. 2018;6(4):
e380–9.
69. Mugo NR, Hong T, Celum C, Donnell D, Bukusi EA, John-Stewart G, et al.
Pregnancy incidence and outcomes among women receiving preexposure pro-
phylaxis for HIV prevention: a randomized clinical trial. JAMA. 2014;312
(4):362–71.
70. Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al.
Tenofovir-based preexposure prophylaxis for HIV infection among African
women. N Engl J Med. 2015;372(6):509–18.
71. Delany-Moretlwe S, Lombard C, Baron D, Bekker L-G, Nkala B, Ahmed K,
et al. Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in
South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-con-
trolled trial. Lancet Infect Dis. 2018;18(11):1241–50.
72. Halpern V, Lie C-C, Feldblum P, Van Damme L. Predictors of pregnancy in
microbicide trials. Contraception. 2011;83(5):436–40.
73. Odutola A, Baisley K, Hayes RJ, Rusizoka M, Tanton C, Weiss HA, et al.
Pregnancy and contraceptive use among women participating in an HIV preven-
tion trial in Tanzania. Sex Transm Infect. 2012;88(6):436–43.
74. Akello CA, Bunge KE, Nakabiito C, Mirembe BG, Fowler MG, Mishra A,
et al. Contraceptive use and pregnancy incidence among women participating in
an HIV prevention trial. J Womens Health. 2017;26(6):670–6.
75. Ahmed K, Baeten JM, Beksinska M, Bekker L-G, Bukusi EA, Donnell D,
et al. HIV incidence among women using intramuscular depot medroxyproges-
terone acetate, a copper intrauterine device, or a levonorgestrel implant for
contraception: a randomised, multicentre, open-label trial. Lancet. 2019;394
(10195):303–13.
76. Cowan FM, Davey C, Fearon E, Mushati P, Dirawo J, Chabata S, et al. Tar-
geted combination prevention to support female sex workers in Zimbabwe
accessing and adhering to antiretrovirals for treatment and prevention of HIV
(SAPPH-IRe): a cluster-randomised trial. Lancet HIV. 2018;5(8):e417–26.
77. Kyongo JK, Kiragu M, Karagu R, Ochieng C, Ngunjiri A, Wachihi C, et al.
How long will they take it? Oral pre-exposure prophylaxis (PrEP) retention for
female sex workers, men who have sex with men and young women in a demon-
stration project in Kenya. The 22nd International AIDS Conference (AIDS
2018); Jul 23-27; Amsterdam; 2018.
78. Diouf O, Sarr M, Gueye D, Mboup A, Toure Kane C, et al. Retention in care
for HIV pre-exposure prophylaxis (PrEP) among sex workers of four public
health centers in Senegal. The 22nd International AIDS Conference (AIDS
2018) Jul 23-27; Amsterdam; 2018.
79. Haberlen SA, Narasimhan M, Beres LK, Kennedy CE. Integration of family
planning services into HIV care and treatment services: a systematic review.
Stud Fam Plann. 2017;48(2):153–77.
80. Shade SB, Kevany S, Onono M, Ochieng G, Steinfeld RL, Grossman D, et al.
Cost, cost-efficiency and cost-effectiveness of integrated family planning and
HIV services. AIDS. 2013;27 Suppl 1:S87–92.
81. Bazzi AR, Yotebieng K, Otticha S, Rota G, Agot K, Ohaga S, et al. PrEP and
the syndemic of substance use, violence, and HIV among female and male sex
workers: a qualitative study in Kisumu, Kenya. J Int AIDS Soc. 2019;22:e25266.
82. Leddy AM, Weiss E, Yam E, Pulerwitz J. Gender-based violence and engage-
ment in biomedical HIV prevention, care and treatment: a scoping review. BMC
Public Health. 2019;19(1):897.
83. Kerrigan D, Mbwambo J, Likindikoki S, Davis W, Mantsios A, Beckham SW,
et al. Project shikamana: community empowerment-based combination HIV pre-
vention significantly impacts HIV incidence and care continuum outcomes
among female sex workers in Iringa, Tanzania. J Acquir Immune Defic Syndr.
2019;82(2):141–8.
84. Reza-Paul S, Lazarus L, Jana S, Ray P, Mugo N, Ngure K, et al. Community
inclusion in PrEP demonstration projects: lessons for scaling up [version 1; peer
review: 2 approved with reservations, 1 not approved]. Gates Open Res.
2019;3:1504.
85. Lafort Y, Greener R, Roy A, Greener L, Ombidi W, Lessitala F, et al. Where
do female sex workers seek HIV and reproductive health care and what moti-
vates these choices? A survey in 4 cities in India, Kenya, Mozambique and South
Africa. PLoS ONE. 2016;11:e0160730.
86. Eakle R, Bourne A, NBothma R, Gomez G, Venter F, Rees H. “They must
understand us as sex workers”: health service perspectives among female sex
workers in the context of PrEP and early ART introduction in the TAPS Demon-
stration Project, South Africa. The 22nd International AIDS Conference (AIDS
2018); Jul 23-27; Amsterdam; 2018.
87. Kerrigan D, Kennedy CE, Morgan-Thomas R, Reza-Paul S, Mwangi P, Win
KT, et al. A community empowerment approach to the HIV response among sex
workers: effectiveness, challenges, and considerations for implementation and
scale-up. Lancet. 2015;385(9963):172–85.
88. Bemelmans M, Baert S, Goemaere E, Wilkinson L, Vandendyck M, van Cut-
sem G, et al. Community-supported models of care for people on HIV treatment
in sub-Saharan Africa. Trop Med Int Health. 2014;19(8):968–77.
89. Penfold E, O'Connor C, Hill N, Bothma R, Khoza T. Enabling factors for
rapid scale-up of services for sex workers in large urban African sites, 2014–
2018 (WEPED811). 10th IAS Conference on HIV Science; Jul 21–24; Mexico
City; 2019.
90. Kennedy CE, Spaulding AB, Brickley DB, Almers L, Mirjahangir J, Packel L,
et al. Linking sexual and reproductive health and HIV interventions: a systematic
review. J Int AIDS Soc. 2010;13(1):26.
91. Narasimhan M, Yeh PT, Haberlen S, Warren CE, Kennedy CE. Integration
of HIV testing services into family planning services: a systematic review.
Reprod Health. 2019;16(1):61.
92. Gombe MM, Mangwendeza Y, Ncube G, Zwangobani N, Prust M, Cakouros
B, et al. Integrating oral HIV pre-exposure prophylaxis (PrEP) in a public family
planning facility and youth center to inform national roll out in Zimbabwe. The
22nd International AIDS Conference; Jul 23-27; Amsterdam; 2018.
93. Mugwanya KK, Pintye J, Kinuthia J, Abuna F, Lagat H, Begnel ER, et al.
Integrating preexposure prophylaxis delivery in routine family planning clinics: a
feasibility programmatic evaluation in Kenya. PLoS Med. 2019;16:e1002885.
94. Nyblade L, Reddy A, Mbote D, Kraemer J, Stockton M, Kemunto C, et al.
The relationship between health worker stigma and uptake of HIV counseling
and testing and utilization of non-HIV health services: the experience of male
and female sex workers in Kenya. AIDS Care. 2017;29(11):1364–72.
95. Scorgie F, Nakato D, Harper E, Richter M, Maseko S, Nare P, et al. ‘We are
despised in the hospitals’: sex workers' experiences of accessing health care in
four African countries. Cult Health Sex. 2013;15(4):450–65.
96. Hargreaves JR, Busza J, Mushati P, Fearon E, Cowan FM. Overlapping HIV
and sex-work stigma among female sex workers recruited to 14 respondent-dri-
ven sampling surveys across Zimbabwe, 2013. AIDS Care. 2017;29(6):675–85.
97. Beckham SW, Shembilu CR, Brahmbhatt H, Winch PJ, Beyrer C, Kerrigan
DL. Female sex workers' experiences with intended pregnancy and antenatal
care services in southern Tanzania. Stud Fam Plann. 2015;46(1):55–71.
98. Ross J, Stover J. Use of modern contraception increases when more meth-
ods become available: analysis of evidence from 1982–2009. Glob Health Sci
Pract. 2013;1(2):203–12.
99. Mwisongo A, Nabyonga-Orem J. Global health initiatives in Africa – gover-
nance, priorities, harmonisation and alignment. BMC Health Serv Res. 2016;16
(4):212.
100. Walsh A, Biesma RG, Brugha R, Harmer A, Walt G, Spicer N. The effects
of global health initiatives on country health systems: a review of the evidence
from HIV/AIDS control. Health Policy Plan. 2009;24(4):239–52.
Bowring AL et al. Journal of the International AIDS Society 2020, 23:e25442
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25442/full | https://doi.org/10.1002/jia2.25442
7
101. The Joint United Nations Programme on HIV/AIDS. Miles to go—closing
gaps, breaking barriers, righting injustices. Geneva: UNAIDS; 2018 [cited 2019
Oct 29]. Available from: https://www.unaids.org/sites/default/files/media_asset/
miles-to-go_en.pdf
102. Awungafac G, Delvaux T, Vuylsteke B. Systematic review of sex work
interventions in sub-Saharan Africa: examining combination prevention
approaches. Trop Med Int Health. 2017;22(8):971–93.
103. Adeagbo O, Mullick S, Pillay D, Chersich M, Morroni C, Naidoo N, et al.
Uptake and early removals of Implanon NXT in South Africa: Perceptions and
attitudes of healthcare workers. S Afr Med J. 2017;107(10):822–6.
104. Ministry of Health, National AIDS & STI Control Program. Guidelines on
use of antiretroviral drugs for treating and preventing HIV in Kenya. Nairobi:
NASCOP; 2018 [cited 2019 Nov 13]. Available from: http://cquin.icap.columb
ia.edu/wp-content/uploads/2017/04/ICAP_CQUIN_Kenya-ARV-Guidelines-2018-
Final_20thAug2018.pdf
105. South Africa National Department of Health. Guidelines for expanding
combination prevention and treatment options: oral Pre-Exposure Prophylaxis
(PrEP) and Test and Treat (T&T). Pretoria: South Africa National Department of
Health; 2016 [cited 2018 May 30]. Available from: http://www.nicd.ac.za/asse
ts/files/PrEP%20and%20TT%20Guidelines%20-%20Final%20Draft%20-%2011%
20May%202016.pdf
106. World Health Organization. WHO Implementation tool for pre-exposure
prophylaxis (PrEP) of HIV infection. Module 1: Clinical. Geneva: WHO; 2017.
107. Charyeva Z, Oguntunde O, Orobaton N, Otolorin E, Inuwa F, Alalade O,
et al. Task shifting provision of contraceptive implants to community health
extension workers: results of operations research in Northern Nigeria. Glob
Health Sci Pract. 2015;3(3):382–94.
108. Hoke TH, Wheeler SB, Lynd K, Green MS, Razafindravony BH, Rasamiha-
jamanana E, et al. Community-based provision of injectable contraceptives in
Madagascar: ‘task shifting’ to expand access to injectable contraceptives. Health
Policy Plan. 2012;27(1):52–9.
109. Stout A, Wood S, Barigye G, Kabore A, Siddo D, Ndione I. Expanding
access to injectable contraception: results from pilot introduction of subcuta-
neous depot medroxyprogesterone acetate (DMPA-SC) in 4 African Countries.
Glob Health Sci Pract. 2018;6(1):55–72.
110. Orenstein WA, Seib K. Beyond vertical and horizontal programs: a diago-
nal approach to building national immunization programs through measles elimi-
nation. Expert Rev Vaccines. 2016;15(7):791–3.
111. Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV/
AIDS Rep. 2018;15(2):190–7.
112. Were D, Atkins K, Musau A, Plotkin M, Curran K. Manifestations of stigma
in the context of a national oral pre-exposure prophylaxis (PrEP) scale-up pro-
gram in Kenya. 10th IAS Conference on HIV Science; Jul 21-24; Mexico City;
2019.
113. Kaida A, Dietrich JJ, Laher F, Beksinska M, Jaggernath M, Bardsley M,
et al. A high burden of asymptomatic genital tract infections undermines the
syndromic management approach among adolescents and young adults in South
Africa: implications for HIV prevention efforts. BMC Infect Dis. 2018;18(1):
499.
114. Shah NS, Kim E, de Maria Hernandez Ayala F, Guardado Escobar ME,
Nieto AI, Kim AA, et al. Performance and comparison of self-reported STI symp-
toms among high-risk populations - MSM, sex workers, persons living with HIV/
AIDS - in El Salvador. Int J STD AIDS. 2014;25(14):984–91.
115. Garrett NJ, Osman F, Maharaj B, Naicker N, Gibbs A, Norman E, et al.
Beyond syndromic management: opportunities for diagnosis-based treatment of
sexually transmitted infections in low- and middle-income countries. PLoS ONE.
2018;13:e0196209.
116. Prevention and control of sexually transmitted infections (STIs) in the era
of oral pre-exposure prophylaxis (PrEP) for HIV. Geneva: World Health Organi-
sation; 2019 [cited 2019 Nov 13]. Available from: https://apps.who.int/iris/bit
stream/handle/10665/325908/WHO-CDS-HIV-19.9-eng.pdf?ua=1
117. Achilles S, Hendrix C, Poloyac S, Hoesley C, Peda M, Gundacker H, et al.
Safety and pharmacokinetics of dapivirine and levonorgestrel vaginal rings for
multipurpose prevention of HIV and pregnancy (Abstract OA12.02LB). HIV
Research for Prevention (HIVR4P); Oct 21–25; Madrid, Spain; 2018.
118. Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE,
Govender V, et al. Use of a vaginal ring containing dapivirine for HIV-1 preven-
tion in women. N Engl J Med. 2016;375(22):2121–32.
119. Nel A, van Niekerk N, Kapiga S, Bekker L-G, Gama C, Gill K, et al. Safety
and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J
Med. 2016;375(22):2133–43.
120. Beckham S, Shembilu C, Galai N, Mwampashi A, Likindikoki S, Mbwambo
J, et al. Comparative acceptability and preferences for oral, injectable, and ring-
based PrEP: A project Shikamana mixed-methods study among Tanzanian female
sex workers. The 22nd International AIDS Conference (AIDS 2018); Jul 23-27;
Amsterdam; 2018.
121. Evaluating the safety and efficacy of long-acting injectable cabotegravir
compared to daily oral TDF/FTC for pre-exposure prophylaxis in HIV-uninfected
women [cited 2019 March 18]. November 6, 2018. Available from: https://clini
caltrials.gov/ct2/show/NCT03164564
Bowring AL et al. Journal of the International AIDS Society 2020, 23:e25442
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25442/full | https://doi.org/10.1002/jia2.25442
8
